Advanced Accelerator Applications to Announce Full-Year 2016 Financial Results on March 23
Mar 15, 2017 11:00 am UTC| Business
SAINT-GENIS-POUILLY, France, March 15, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear Medicine (MNM), today announced that the...
Mar 15, 2017 11:00 am UTC| Business
- Achieved primary objective of 12-month survival rate, demonstrating axalimogene filolisbac is an active therapy in metastatic cervical cancer - Unprecedented 12-month survival rate for metastatic cervical cancer...
Ferrellgas Expands Footprint in Southern California With Acquisition of Valley Center Propane
Mar 15, 2017 11:00 am UTC| Business
OVERLAND PARK, Kan., March 15, 2017 -- Ferrellgas Partners, L.P. (NYSE:FGP) today announced the acquisition of Valley Center Propane, an independent propane retailer based in Valley Center, California. The transaction...
Mar 15, 2017 11:00 am UTC| Business
-- Provides Update on Clinical and Other Developments-- Initiates Financial Guidance for Full Year 2017-- Management to Host Conference Call at 8:00 a.m. ET today MALVERN, Pa., March 15, 2017 -- Aclaris Therapeutics,...
Summit Therapeutics to Present at the Oppenheimer 27th Annual Healthcare Conference
Mar 15, 2017 11:00 am UTC| Business
OXFORD, United Kingdom, March 15, 2017 -- Summit Therapeutics plc (NASDAQ:SMMT)(AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile...
Bio-Path Holdings Reports Full Year 2016 Financial Results
Mar 15, 2017 11:00 am UTC| Business
HOUSTON, March 15, 2017 -- Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid...
VBL Therapeutics to Present at the Oppenheimer 27th Annual Healthcare Conference
Mar 15, 2017 11:00 am UTC| Business
TEL AVIV, Israel, March 15, 2017 -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today...